Ropes & Gray represented Collaborative Fund in the transaction. Collaborative Fund announced its investment in Smash Kitchen, a new business venture by actor and producer Glen...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Arbor Biotechnologies in the transaction. Arbor Biotechnologies announced its $73.9 million Series C financing to support the advancement of its novel gene...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Evergreen Nephrology in the transaction. Evergreen Nephrology, a leader in value-based kidney care, announced its $130 million fund raise led by Rubicon...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Dash Bio in the transaction. Dash Bio announced a $6.5 million seed financing round led by Freestyle Capital. Swift Ventures, LifeX Ventures...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Crosspoint Capital Partners in the transaction. SynthBee, Inc. (SynthBee) announced it has secured $20 million in seed funding. The funding was provided...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised AbbVie on the deal. AbbVie (NYSE: ABBV), and Umoja Biopharma (Umoja) Umoja Biopharma announced two exclusive option and license agreements to develop multiple in-situ...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Genesis Therapeutics in the fundraising, and Cooley represented Andreessen Horowitz (a16z) Bio + Health Tech Investments. Genesis Therapeutics announced that it has...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pfizer on the deal. Pfizer announced a strategic collaboration with Flagship Pioneering to create a new pipeline of innovative medicines. The collaboration...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pfizer on the deal. Pfizer announced its strategic investment in and collaboration with CellCentric, which includes $25 million to help finance further development...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ovid Therapeutics on the deal. Ovid Therapeutics announced a collaboration with Graviton Bioscience Corporation under which Ovid obtained exclusive rights to develop...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Solarea Bio on the deal. Solarea Bio, a clinical stage biotechnology developing food-derived microbial-based solutions to aid human health, announced a first closing...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Crosspoint Capital Partners on the deal. Crosspoint Capital Partners acted as leading investor in a €65 million Series A follow-on funding round...
You must be a Standard 1 Year member to access this content.
